Elicio Therapeutics, Inc. (ELTX) Total liabilities 2020–2022
Elicio Therapeutics, Inc. (ELTX) total liabilities at each fiscal year-end, per SEC filings.
$13.7MFY2022 · since FY2020: $137.8M → $13.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $13.7M | -8.4% |
| FY2021 | $15.0M | -89.1% |
| FY2020 | $137.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX RevenueELTX Net incomeELTX Net marginELTX Gross profitELTX Gross marginELTX Operating incomeELTX Operating marginELTX Operating cash flowELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Shareholders’ equityELTX overview →